| abstract |
Compositions and methods for treating multiple myeloma (MM), acute myelogenous lymphoma (AML) or myeloproliferative disease (MPD) in a human patient in need of treatment. The method entails administering to the patient an effective amount of seldulatinib. In accordance with the present invention, for example, in a human patient in need of treatment, a method of treating multiple myeloma (MM), acute myelogenous lymphoma (AML) or myeloproliferative disease (MPD) comprising: Or administering an effective amount of a pharmaceutically acceptable salt thereof, wherein said effective amount is from about 5 mg to about 150 mg. [Selection] Figure 7 |